Skip to main content

Dyadic International (US:DYAI) — Company Overview, News & Financial Data

Dyadic International logo
DYAIDyadic International
Dyadic International primary media
Company profile

Dyadic International

About

Explore United States companies

Dyadic International (NASDAQ:DYAI) is a biotechnology company focused on developing, manufacturing, and commercializing a wide range of biologic products. Utilizing its proprietary C1-cell protein production platform, Dyadic aims to create efficient and cost-effective biopharmaceuticals for industrial, animal, and human health applications. Projects include developing vaccines, monoclonal antibodies, and other therapeutic proteins. Dyadic's ultimate objective is to improve health standards globally by making biologic vaccines and drugs more accessible and affordable to healthcare systems and patients around the world.

Snapshot

Public USOwnership
1979Year founded
44Employees
Jupiter, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
Jupiter, US

Products and/or services of Dyadic International

  • C1 Protein Production Platform - A proprietary biotechnology platform for developing and producing low-cost, high-performance biological products.
  • Biopharmaceuticals Development - Focused on developing and licensing recombinant proteins and antibodies for human health applications.
  • Industrial Enzymes - Creating and optimizing enzymes for use in industrial processes, including biofuels, paper, and textiles.
  • Animal Health Solutions - Developing vaccines and antibodies for livestock protection and productivity enhancement.
  • Biosecurity - Working on solutions for preventing and controlling infectious diseases in crops and livestock.
  • Research Partnerships - Collaborating with pharmaceutical and biotechnology companies, academic institutions, and government agencies for biotech advancements.

Dyadic International executive team

  • Mr. Mark A. EmalfarbFounder, CEO & Director
  • Mr. Joseph P. HazeltonPresident & COO
  • Ms. Ping Wang Rawson CPA, M.B.A.Chief Financial Officer
  • Ms. Ana Gómez RodriguezSecretary of the Board